<html>
<head>PUBMED IDs for NAALADL2</head>
<body bgcolor='#C5F0F2'><h1>NAALADL2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15168106/'>A giant novel gene undergoing extensive alternative splicing is severed by a Cornelia de Lange-associated translocation breakpoint at 3q26.3.</a> May 29  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15168101/'>Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.</a> May 29  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16160854/'>Molecular analysis of a constitutional complex genome rearrangement with 11 breakpoints involving chromosomes 3, 11, 12, and 21 and a approximately 0.5-Mb submicroscopic deletion in a patient with mild mental retardation.</a> September 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/19132087/'>A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease.</a> May 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22106001/'>Chromosomal loss of 3q26.3-3q26.32, involving a partial neuroligin 1 deletion, identified by genomic microarray in a child with microcephaly, seizure disorder, and severe intellectual disability.</a> June 21  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24240687/'>N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.</a> April 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25939597/'>Two susceptibility loci identified for prostate cancer aggressiveness.</a> March 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25939554/'>Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype.</a> August 25  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27629806/'>Genomic findings in patients with clinical suspicion of 22q11.2 deletion syndrome.</a> September 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28145423/'>Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.</a> February 2  2017<br></body></html>
